J. Alan Crunkleton
Chief Operating Officer at MateraCor, Inc.
Profile
J.
Alan Crunkleton is currently the Chief Operating Officer at MateraCor, Inc. He previously worked as the President, Chief Executive Officer & Director at Correx, Inc. and as the President & Chief Executive Officer at Northridge Tri-Modality Imaging, Inc. He holds graduate and doctorate degrees from the Massachusetts Institute of Technology and a doctorate degree from the University of Massachusetts.
J. Alan Crunkleton active positions
Companies | Position | Start |
---|---|---|
MateraCor, Inc.
MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Chief Operating Officer | - |
Former positions of J. Alan Crunkleton
Companies | Position | End |
---|---|---|
Correx, Inc.
Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Chief Executive Officer | 28/02/2014 |
Northridge Tri-Modality Imaging, Inc.
Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Chief Executive Officer | - |
Training of J. Alan Crunkleton
Massachusetts Institute of Technology | Doctorate Degree |
University of Massachusetts | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Correx, Inc.
Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Health Technology |
Northridge Tri-Modality Imaging, Inc.
Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Health Technology |
MateraCor, Inc.
MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Health Technology |
- Stock Market
- Insiders
- J. Alan Crunkleton